Heterozygous variant fibrinogen γA289V (Kanazawa III) was confirmed as hypodysfibrinogenemia by plasma and recombinant fibrinogens
- 20 January 2020
- journal article
- research article
- Published by Wiley in International Journal of Laboratory Hematology
- Vol. 42 (2), 190-197
- https://doi.org/10.1111/ijlh.13152
Abstract
Introduction Congenital fibrinogen disorders are classified as afibrinogenemia, hypofibrinogenemia, dysfibrinogenemia, and hypodysfibrinogenemia. However, difficulties are associated with discriminating between dysfibrinogenemia, hypofibrinogenemia, and hypodysfibrinogenemia using routine analyses. We previously reported a heterozygous variant fibrinogen (γA289V; Kanazawa III) as hypodysfibrinogenemia; however, the same variant had previously been described as hypofibrinogenemia. To clarify the production of γA289V fibrinogen, we expressed recombinant γA289V (r‐γA289V) fibrinogen and compared it with wild‐type (WT) and adjacent recombinant variant fibrinogens. Methods Target mutations were introduced into a fibrinogen γ‐chain expression vector by site‐directed mutagenesis, and the vector was then transfected into Chinese hamster ovary cells to produce recombinant fibrinogen. Fibrinogen was purified from the plasma of the proposita, and culture media and fibrinogen functions were analyzed using fibrin polymerization, plasmin protection, and FXIIIa‐catalyzed fibrinogen cross‐linking. Results The fibrinogen concentration ratio of the culture media to cell lysates was markedly lower for r‐γA289V fibrinogen than for WT. Because the secretion of recombinant γF290L (r‐γF290L) fibrinogen was similar to WT, we compared r‐γF290L fibrinogen functions with WT. The fibrin polymerization of Kanazawa III plasma (K‐III) fibrinogen was significantly weaker than normal plasma fibrinogen. Moreover, K‐III fibrinogen showed a markedly reduced “D:D” interaction. However, all functions of r‐γF290L fibrinogen were similar to WT. An in silico analysis confirmed the above results. Conclusion The present results demonstrated that γA289 is crucial for the γ‐module structure, and the γA289V substitution markedly reduced fibrinogen secretion. Moreover, K‐III fibrinogen showed markedly reduced fibrin polymerization and “D:D” interactions. γA289V fibrinogen was confirmed as hypodysfibrinogenemia.Keywords
Funding Information
- Japan Society for the Promotion of Sicences KAKENHI (JP17K09009)
This publication has 19 references indexed in Scilit:
- Recommendations for nomenclature on fibrinogen and fibrinJournal of Thrombosis and Haemostasis, 2009
- Fibrinogen and fibrin structure and functionsJournal of Thrombosis and Haemostasis, 2005
- Hypofibrinogenaemia associated with a novel heterozygous γ289 Ala→Val substitution (fibrinogen Dorfen)Thrombosis and Haemostasis, 2004
- A model of fibrin formation based on crystal structures of fibrinogen and fibrin fragments complexed with synthetic peptidesProceedings of the National Academy of Sciences of the United States of America, 2000
- Crystal Structure of Fragment Double-D from Human Fibrin with Two Different Bound Ligands,Biochemistry, 1998
- Severely Impaired Polymerization of Recombinant Fibrinogen γ-364 Asp → His, the Substitution Discovered in a Heterozygous IndividualPublished by Elsevier BV ,1997
- The Role of βγ and αγ Complexes in the Assembly of Human FibrinogenPublished by Elsevier BV ,1996
- The role of fibrinogen D domain intermolecular association sites in the polymerization of fibrin and fibrinogen Tokyo II (gamma 275 Arg-->Cys).JCI Insight, 1995
- FIBRINOGEN AND FIBRINAnnual Review of Biochemistry, 1984
- A New Inherited Coagulation Disorder Caused by an Abnormal Fibrinogen (‘Fibrinogen Baltimore’)Nature, 1965